Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
01/2002
01/31/2002US20020013374 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors
01/31/2002US20020013352 Novel substituted diamine derivatives useful as motilin antagonists
01/31/2002US20020013324 N-substituted imide derivatives with serotonergic activity
01/31/2002US20020013317 For therapy and prophylaxis of psychotic disorders such as schizophrenia and other central nervous system disease
01/31/2002US20020013296 Treating with agonists at kappa opioid receptors such as methyl-4-(2-glycyl-4-(trifluoromethylphenyl)acetyl)-3-(R,S)-((1 -pyrrolidinyl)-methyl)-1-piperazinecarboxylate
01/31/2002US20020012879 Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same
01/31/2002DE10035144A1 Cyclische Aminosäurederivate Cyclic amino acid derivatives
01/31/2002DE10034812A1 New N,N'-bis-(3-aminophenyl)-alkylene diamines and salts are used as coupler components in oxidation colorants for keratin fibers, e.g. wool, feathers and fur, and especially human hair
01/31/2002CA2415606A1 Capsaicin receptor ligands
01/31/2002CA2415046A1 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide
01/31/2002CA2410562A1 Colchinol derivatives as angiogenesis inhibitors
01/30/2002EP1175383A1 Glucocorticoid receptor modulators
01/30/2002CN1333769A Thiourea inhibitors of herps viruses
01/30/2002CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
01/30/2002CN1333747A ((Aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
01/30/2002CN1333746A Molecular scaffolds acting as templates comprising carbamate linkages
01/29/2002US6342633 O-benzyl oxime ether derivatives and their use as pesticides
01/29/2002US6342607 Intermediates for preparation of neurokinin antagonists
01/29/2002US6342512 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals
01/29/2002US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/24/2002WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/24/2002WO2002006223A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
01/24/2002WO2002006213A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
01/24/2002WO2002006207A2 Novel coupling components for oxidation colouring agents
01/24/2002WO2002006189A2 Aniline derivatives
01/24/2002US20020010344 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
01/24/2002US20020010337 Stilbene compounds comprising an adamantyl group, compositions and methods thereof
01/24/2002US20020010173 Reacting an amide derivative with a piperidine containing guanidine group to produce the product
01/24/2002DE19963234A1 New N,N-disubstituted piperazine and diazacycloheptane derivatives useful in treatment of hyperlipidemia, atherosclerosis, diabetes mellitus, adiposity and pancreatitis
01/24/2002DE10033016A1 Verfahren zur Herstellung von 3,3-Diarylpropylaminen A process for the preparation of 3,3-Diarylpropylaminen
01/24/2002CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/23/2002EP1173415A1 Diphenylurea derivatives
01/23/2002EP1173223A2 Conjugates as therapies for cancers and prostate diseases
01/23/2002EP1173161A2 Glucamine compounds for treating hepatitis virus infections
01/23/2002CN1332734A Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity
01/23/2002CN1332725A Thiourea inhibitors of herpes viruses
01/23/2002CN1332724A N-arylsulfonyl amino acid omega amides
01/23/2002CN1332142A Diglycol material for preparing morpholine
01/22/2002US6340761 Amination and dehydrohalogenation with piperidine compounds
01/22/2002US6340709 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
01/22/2002US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
01/22/2002US6340691 Treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
01/22/2002US6340682 Diamide compound and drugs containing the same
01/17/2002WO2002004434A1 Colchinol derivatives as vascular damaging agents
01/17/2002WO2002004433A2 Melanin concentrating hormone receptor ligands
01/17/2002WO2002004419A2 α,α-DIBROMO-α-CHLORO-ACETOPHENONES AS SYNTHONS
01/17/2002WO2002004407A2 7-substituted tetracycline compounds
01/17/2002WO2002004406A2 9-substituted minocycline compounds
01/17/2002WO2002004399A1 Method for producing 3,3-diarylpropylamines
01/17/2002WO2001059067A3 A group of anti-cancer compounds with specific structure and their production method
01/17/2002WO2001005763A3 Compounds with activity on muscarinic receptors
01/17/2002US20020007085 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
01/17/2002US20020007064 For prevention of psychotic disorders such as schizophrenia and other central nervous system diseases
01/17/2002US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
01/17/2002US20020006922 Metalloprotease inhibitors
01/17/2002US20020006899 Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
01/17/2002DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments
01/17/2002CA2415459A1 .alpha.,.alpha.-dibromo-.alpha.-chloro-acetophenones as synthons
01/17/2002CA2414198A1 Melanin concentrating hormone receptor ligands
01/17/2002CA2411160A1 Colchinol derivatives as vascular damaging agents
01/16/2002EP1172359A1 N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-$g(a) PRODUCTION INHIBITOR
01/16/2002EP1171432A1 Adamantane derivatives
01/16/2002EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
01/16/2002EP1171419A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
01/16/2002CN1077790C Agent for treating gluaucoma and agent for reducing eye pressure
01/15/2002US6339154 (2-Substituted oxyphenyl) alkanamide derivative, hair growth promoter and external composition for skin using the same
01/15/2002US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis
01/10/2002WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
01/10/2002WO2002002546A1 EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM
01/10/2002WO2002002538A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen
01/10/2002WO2002002522A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
01/10/2002WO2002002520A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002519A2 THROMBIN OR FACTOR Xa INHIBITORS
01/10/2002WO2002002518A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002512A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002511A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
01/10/2002WO2002002506A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002505A2 Compounds to treat alzheimer's disease
01/10/2002WO2001042192A3 Vla-4 integrin antagonists
01/10/2002CA2414464A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
01/10/2002CA2413241A1 Thrombin or factor xa inhibitors
01/10/2002CA2410972A1 Compounds to treat alzheimer's disease
01/10/2002CA2410680A1 Compounds to treat alzheimer's disease
01/10/2002CA2410651A1 Compounds to treat alzheimer's disease
01/09/2002EP1170288A2 Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists
01/09/2002EP1170281A1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof
01/09/2002EP1169308A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
01/09/2002EP1169302A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
01/09/2002EP1169301A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions
01/09/2002EP1169300A1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
01/09/2002EP1169294A2 Pharmaceutical compounds
01/09/2002EP1169031A1 Antimicrobial agents
01/09/2002EP1021473B1 Bis(alkylamino)alkylether compounds and the use thereof
01/09/2002EP0917531B1 Piperazine derivatives and oxydation dyes
01/09/2002EP0693052B1 Deallylation reagent and deallylation method using said reagent
01/09/2002CN1330637A Compounds useful in treatment of infammatory diseases
01/09/2002CN1330631A Amide derivatives which are useful as cell factor inhibitors
01/09/2002CN1330067A 1,1-and 1,2-twice subsitituted cyclopropane compound, preparation method thereof and drug composite containing their
01/09/2002CN1077570C Sulfamate compounds containing N-substituted carbanoyl and process for preparing the same
01/08/2002US6337398 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors